结核分支杆菌耐药现状及相关检测技术价值
Current Status of Drug Resistant Mycobacterium tuberculosis and the Value of Relevant Detection Techniques
DOI: 10.12677/ACM.2023.134937, PDF,   
作者: 雍彧滔, 廖 璞*：重庆医科大学，重庆；中国科学院重庆绿色智能技术研究院，重庆；中国科学院大学重庆学院，重庆；重庆市人民医院检验科，重庆
关键词: 结核分枝杆菌；耐药检测；运用价值；未来发展；Mycobacterium tuberculosis； Drug Resistance Detection； Application Value； Future Development
摘要: 结核病是一种由结核分支杆菌(Mycobacterium tuberculosis)引起的慢性感染性疾病，结核分支杆菌的耐药性问题日益严重，已成为全球公共卫生的重要问题。本文综述了结核分支杆菌耐药现状及相关检测技术运用价值。介绍了结核分支杆菌的耐药现状及相关检测技术。探讨了目前耐药性相关检测技术运用价值、局限性及未来发展方向。结核分支杆菌检测技术在结核病的预防、诊断、治疗和控制中发挥着重要作用。它们可以提高结核病的早期诊断率和治疗成功率，减少疾病的传播和死亡率，同时还可以帮助卫生机构更好地掌握结核病的流行情况和传播路径，从而制定更加有效的预防措施。随着技术的不断进步和完善，结核分支杆菌耐药性检测技术将会得到更广泛的应用，从而更好地服务于结核病的预防、诊断和治疗工作。
Abstract: Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis (MTB). The problem of drug resistance of MTB is becoming more and more serious, and it has become an im-portant problem of global public health. This article reviewed the status of drug resistance of My-cobacterium tuberculosis and the application value of relevant detection techniques. The current situation of drug resistance of Mycobacterium tuberculosis and related detection techniques were introduced. The application value, limitation and future development of drug resistance-related detection technology were discussed. Detection of Mycobacterium tuberculosis plays an important role in the prevention, diagnosis, treatment and control of tuberculosis. They can increase the rate of early diagnosis and successful treatment of tuberculosis, reduce the spread and mortality of the disease, and help health agencies to better understand the prevalence and transmission routes of tuberculosis, to develop more effective preventive measures. With the continuous progress and improvement of technology, the detection of drug resistance of Mycobacterium tuberculosis will be more widely used, so as to better serve the prevention, diagnosis and treatment of tuberculosis.
文章引用：雍彧滔, 廖璞. 结核分支杆菌耐药现状及相关检测技术价值[J]. 临床医学进展, 2023, 13(4): 6699-6707. https://doi.org/10.12677/ACM.2023.134937

参考文献

[1] World Health Organization (2020) Global Tuberculosis Report 2020. World Health Organization, Geneva.
https://www.who.int/publications/i/item/9789240013131
[2] Gygli, S.M., Borrell, S., Trauner, A. and Gagneux, S. (2017) Antimicrobial Resistance in Mycobacterium tuberculosis: Mechanistic and Evolutionary Perspec-tives. FEMS Microbiology Reviews, 41, 354-373. [Google Scholar] [CrossRef] [PubMed]
[3] Sharma, D., Dhuriya, Y.K., Deo, N. and Bisht, D. (2017) Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis. Frontiers in Microbiology, 8, Article 2452. [Google Scholar] [CrossRef] [PubMed]
[4] Seung, K.J., Keshavjee, S. and Rich, M.L. (2015) Multi-drug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harbor Perspectives in Medi-cine, 5, a017863. [Google Scholar] [CrossRef] [PubMed]
[5] Migliori, G.B., Tiberi, S., Zumla, A., Petersen, E., Chakaya, J.M., Wejse, C., et al. (2020) MDR/XDR-TB Management of Patients and Contacts: Challenges Facing the New Decade. The 2020 Clinical Update by the Global Tuberculosis Network. International Journal of Infectious Diseases, 92, S15-S25.
[6] Outhred, A.C., Britton, P.N. and Marais, B.J. (2017) Drug-Resistant Tuberculosis—Primary Transmis-sion and Management. The Journal of Infection, 74, S128-S135. [Google Scholar] [CrossRef] 
[7] Sulis, G., Roggi, A., Matteelli, A. and Raviglione, M.C. (2014) Tuberculosis: Epidemiology and Control. Mediterranean Journal of Hematology and Infectious Diseases, 6, e2014070. [Google Scholar] [CrossRef] [PubMed]
[8] Mirzayev, F., Viney, K., Linh, N.N., Gonzalez-Angulo, L., Gegia, M., et al. (2021) World Health Organization Recommendations on the Treatment of Drug-Resistant Tuberculosis, 2020 Update. The European Respiratory Journal, 57, Article ID: 2003300. [Google Scholar] [CrossRef] [PubMed]
[9] Conradie, F., Diacon, A.H., Ngubane, N., Howell, P., Everitt, D., et al. (2020) Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. The New England Journal of Medicine, 382, 893-902. [Google Scholar] [CrossRef] 
[10] Seaworth, B.J. and Griffith, D.E. (2017) Therapy of Multi-drug-Resistant and Extensively Drug-Resistant Tuberculosis. Microbiology Spectrum, 5. [Google Scholar] [CrossRef] 
[11] Cirillo, D.M., Miotto, P. and Tortoli, E. (2017) Evolution of Phenotypic and Molecular Drug Susceptibility Testing. In: Gagneux, S., Ed., Strain Variation in the Myco-bacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control. Advances in Experimental Medicine and Biology, Vol. 1019, Springer, Cham, 221-246. [Google Scholar] [CrossRef] [PubMed]
[12] Migliori, G.B., Matteelli, A., Cirillo, D. and Pai, M. (2008) Diagnosis of Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis: Current Standards and Challenges. The Canadian Journal of Infectious Diseases & Medical Microbiology, 19, 169-172. [Google Scholar] [CrossRef] [PubMed]
[13] Deberu, O., Nkrumah, B., Sylverken, A.A., Sambian, D., et al. (2021) Common Bacteria in Sputum or Gastric Lavage of Patients Presenting with Signs and Symptoms of Lower Respiratory Tract Infections. The Pan African Medical Journal, 38, Article 383. [Google Scholar] [CrossRef] [PubMed]
[14] Koh, W.-J., Ko, Y., Kim, C.-K., Park, K.S. and Lee, N.Y. (2012) Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System. Annals of Laboratory Medicine, 32, 264-269. [Google Scholar] [CrossRef] [PubMed]
[15] Makaen, J. and Maure, T. (2014) Bleach Processed Smear for Acid Fast Bacilli Staining in Papua New Guinea. Laboratory Medicine, 45, e140-e141. [Google Scholar] [CrossRef] 
[16] Vilchèze, C. and Kremer, L. (2017) Acid-Fast Positive and Acid-Fast Negative Mycobacterium tuberculosis: The Koch Paradox. Microbiology Spectrum, 5. [Google Scholar] [CrossRef] 
[17] Zhao, D., Yang, X.-M., Chen, Q.-Y., Zhang, X.-S., Guo, C.-J. and Che, X.-Y. (2012) A Modified Acid-Fast Staining Method for Rapid Detection of Mycobacterium tuber-culosis. Journal of Microbiological Methods, 91, 128-132. [Google Scholar] [CrossRef] [PubMed]
[18] Monaghan, M.L., Doherty, M.L., Collins, J.D., Kazda, J.F. and Quinn, P.J. (1994) The Tuberculin Test. Veterinary Microbiology, 40, 111-124. [Google Scholar] [CrossRef] [PubMed]
[19] Chadha, V.K. (2001) Tuberculin Test. Indian Journal of Pedi-atrics, 68, 53-58. [Google Scholar] [CrossRef] 
[20] Farzam, B., Imani Fooladi, A.A., Izadi, M., Hossaini, H.M. and Feizabadi, M.M. (2014) Comparison of cyp141 and IS6110 for Detection of Mycobacterium tuberculosis from Clinical Specimens by PCR. Journal of Infection and Public Health, 8, 32-36. [Google Scholar] [CrossRef] [PubMed]
[21] Narang, A., Marras, S.A.E., Kurepina, N., Chauhan, V., Shashkina, E., et al. (2022) Ultrasensitive Detection of Multidrug-Resistant Mycobacterium tuberculosis Using SuperSelective Pri-mer-Based Real-Time PCR Assays. International Journal of Molecular Sciences, 23, Article No. 15752. [Google Scholar] [CrossRef] [PubMed]
[22] Chen, G., Qin, C.-J., Wu, M.-Z., Wu, B.-B., Luo, W.-R., et al. (2022) Clinical Application of RT-PCR in Tuberculosis DNA Detection Combined with TB-IGRA in the Diagnosis of Sputum Smear-Negative Pulmonary Tuberculosis. Acta Clinica Croatica, 61, 193-197. [Google Scholar] [CrossRef] [PubMed]
[23] Opota, O., Mazza-Stalder, J., Greub, G. and Jaton, K. (2019) The Rapid Molecular Test Xpert MTB/RIF Ultra: Towards Improved Tuberculosis Diagnosis and Rifampicin Resistance De-tection. Clinical Microbiology and Infection, 25, 1370-1376. [Google Scholar] [CrossRef] [PubMed]
[24] Kim, S.-K., Chang, J., Choi, S.-H., Sung, H. and Kim, M.-N. (2021) Performance of Xpert MTB/RIF for the Diagnosis of Extrapulmonary Tuberculosis. Clinical Laboratory, 67. [Google Scholar] [CrossRef] 
[25] Steingart, K.R., Schiller, I., Horne, D.J., Pai, M., Boehme, C.C., et al. (2014) Xpert® MTB/RIF Assay for Pulmonary Tuberculosis and Rifampicin Resistance in Adults. The Cochrane Database of Systematic Reviews, No. 1, Article ID: CD009593. [Google Scholar] [CrossRef] 
[26] Wu, D., Kang, J., Li, B. and Sun, D. (2017) Evaluation of the RT-LAMP and LAMP Methods for Detection of Mycobacterium Tuberculosis. Journal of Clinical Laboratory Analysis, 32, e22326. [Google Scholar] [CrossRef] [PubMed]
[27] Acharya, B., Acharya, A., Gautam, S., Ghimire, S.P., Mishra, G., et al. (2020) Advances in Diagnosis of Tuberculosis: An Update into Molecular Diagnosis of Mycobacterium tuberculosis. Molecular Biology Reports, 47, 4065-4075. [Google Scholar] [CrossRef] [PubMed]
[28] Wu, W., Cheng, P., Lyu, J., Zhang, Z. and Xu, J. (2018) Tag Array Gene Chip Rapid Diagnosis Anti-Tuberculosis Drug Resistance in Pulmonary Tuberculosis—A Feasibility Study. Tuberculosis, 110, 96-103. [Google Scholar] [CrossRef] [PubMed]
[29] Meehan, C.J., Goig, G.A., Kohl, T.A., Kohl, T.A., Verboven, L., et al. (2019) Whole Genome Sequencing of Mycobacterium tuberculosis: Current Standards and Open Issues. Nature Re-views Microbiology, 17, 533-545. [Google Scholar] [CrossRef] [PubMed]
[30] Ai, J.-W., Zhou, X., Xu, T., Yang, M., Chen, Y., et al. (2019) CRISPR-Based Rapid and Ultra-Sensitive Diagnostic Test for Mycobacterium tuberculosis. Emerging Microbes & In-fections, 8, 1361-1369. [Google Scholar] [CrossRef] [PubMed]
[31] Huang, Z., LaCourse, S.M., Kay, A.W., Stern, J., Escudero, J.N., et al. (2022) CRISPR Detection of Circulating Cell-Free Mycobacterium tuberculosis DNA in Adults and Children, Including Children with HIV: A Molecular Diagnostics Study. The Lancet Microbe, 3, E482-E492. [Google Scholar] [CrossRef] 
[32] Sam, I.K., Chen, Y.-Y., Ma, J., Li, S.-Y., Ying, R.-Y., et al. (2021) TB-QUICK: CRISPR-Cas12b-Assisted Rapid and Sensitive Detection of Mycobacterium tuberculosis. The Journal of Infection, 83, 54-60. [Google Scholar] [CrossRef] [PubMed]
[33] Ahmed, M., Tezera, L.B., Elkington, P.T. and Leslie, A.J. (2022) The Paradox of Immune Checkpoint Inhibition Re-Activating Tuberculosis. The European Respiratory Journal, 60, Ar-ticle ID: 2102512. [Google Scholar] [CrossRef] [PubMed]
[34] Kim, Y., Han, M.-H., Kim, S.-W. and Won, D.I. (2022) CD69 Flow Cytometry to Complement Interferon-γ Release Assay for Active Tuberculosis. Cytometry Part B: Clinical Cytom-etry, 102, 471-486. [Google Scholar] [CrossRef] [PubMed]
[35] Cantera, J.L., Lillis, L.M., Peck, R.B., Moreau, E., Schouten, J.A., Da-vis, P., Drain, P.K., Andama, A., Pinter, A., Kawasaki, M., Källenius, G., Sundling, C., Dobos, K.M., Flores, D., Chat-terjee, D., Murphy, E., Halas, O.R. and Boyle, D.S. (2022) Performance of Novel Antibodies for Lipoarabinomannan to Develop Diagnostic Tests for Mycobacterium tuberculosis. PLOS ONE, 17, e0274415. [Google Scholar] [CrossRef] [PubMed]
[36] Oommen, S. and Banaji, N. (2017) Laboratory Diagnosis of Tuberculosis: Advances in Technology and Drug Susceptibility Testing. Indian Journal of Medical Microbiology, 35, 323-331. [Google Scholar] [CrossRef] 
[37] Zhou, X., Wu, H., Ruan, Q., Jiang, N., Chen, X., et al. (2019) Clinical Evaluation of Diagnosis Efficacy of Active Mycobacterium tuberculosis Complex Infection via Meta-genomic Next-Generation Sequencing of Direct Clinical Samples. Frontiers in Cellular and Infection Microbiology, 9, Article 351. [Google Scholar] [CrossRef] [PubMed]
[38] Shafeque, A., Bigio, J., Hogan, C.A., Pai, M. and Banaei, N. (2020) Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence? Journal of Clinical Microbi-ology, 58, e01950-19. [Google Scholar] [CrossRef] 
[39] Walker, T.M., Miotto, P., Köser, C.U., Fowler, P.W., et al. (2022) The 2021 WHO Catalogue of Mycobacterium tuberculosis Complex Mutations Associated with Drug Resistance: A Geno-typic Analysis. The Lancet Microbe, 3, e265-e273.
[40] Gholoobi, A., Masoudi-Kazemabad, A., Meshkat, M. and Meshkat, Z. (2014) Comparison of Culture and PCR Methods for Diagnosis of Mycobacterium tuberculosis in Different Clinical Specimens. Jundishapur Journal of Microbiology, 7, e8939. [Google Scholar] [CrossRef] [PubMed]
[41] Lu, C., Jing, H., Lu, Z. and Deng, Y. (2021) Comparison of Different Methods for the Diagnosis of Mycobacterium Tuberculo-sis and Rifampin-Resistance. Clinical Laboratory, 67. [Google Scholar] [CrossRef] 

为你推荐